In VivoAutocratic, bureaucratic, charismatic, democratic. How leaders exercise power is to a large extent a function of the company’s societal context. But while societal norms and cultures differ, all leade
ScripHemab Therapeutics has made a lot of progress since the last time it announced a major funding round, including taking its first drug candidate into a Phase I/II trial and identifying a second candid